Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Acute Megakaryoblastic Leukemia
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug, Radiation, Other, Procedure
Participants:
10
Start Date:
March 25, 2021
Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR5Δ32 Homozygous or Heterozygous Cord Blood Unit in Patients With HIV and Hematological Malignancies
Clinical Trial
Status:
Recruiting
Participants:
1000
Start Date:
March 28, 2019
Longitudinal Studies of Patient With FPDMM
Search for trials
Clinical Trial
Status:
Active, not recruiting
Phase:
N/A
Intervention Type:
Drug, Other
Participants:
26
Start Date:
October 9, 2015
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Other, Drug
Participants:
174
Start Date:
June 2011
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (EQol-MDS)
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 3
Intervention Type:
Drug, Other
Participants:
717
Start Date:
April 2008
A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
Clinical Trial
Status:
Active, not recruiting
Intervention Type:
Other, Genetic
Participants:
600
Start Date:
October 2006
Multidrug Resistance Protein Gene Polymorphisms in Acute Myeloid Leukemia. A CALGB Leukemia Tissue Bank Project
Clinical Trial
Status:
Active, not recruiting
Intervention Type:
Genetic, Other
Participants:
735
Start Date:
May 2006
Molecular Genetic Studies of Acute Myeloid Leukemia (AML) With Normal Cytogenetics. A CALGB Leukemia Tissue Bank Project
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2
Intervention Type:
Procedure, Biological, Radiation, Drug
Participants:
50
Start Date:
February 8, 2000
Autologous Bone Marrow Transplantation for Non-M3 Acute Myeloid Leukemia (AML) in First Remission in Patients </=60 Years of Age Using Busulfan/Fractionated Total Body Irradiation (FTBI) and VP16 as the Preparative Regimen
Showing 1-8 of 8